Apollo, an alternative asset manager, has partnered with Sofinnova Partners, a life sciences venture capital firm.
Together, the firms will offer a range of capital services to support new therapeutic and biotechnology firms.
Antoine Papiernik, chairman of Sofinnova Partners, commented, “This strategic partnership will enable Sofinnova to double down on what it does best: support innovation and build companies through long-term relationships with visionary entrepreneurs. We are poised to accelerate our strategy, solidify our position as a leading global player, and enhance our product offering to our investors – setting the stage for new levels of growth and expansion.”